Looks like POSC is a real entity. Impressive new hire.
Positron Corporation Hires Former Sales Director of Nidek as Executive VP of Sales Tuesday July 13, 4:19 pm ET David Yeh Joins Positron to Head Worldwide Positron Sales and Marketing Program
HOUSTON--(BUSINESS WIRE)--July 13, 2004--Positron Corporation (OTCBB:POSC - News) manufacturer of positron emission tomography ("PET") scanners, today announced that it hired David Yeh as Executive Vice President of Sales and Marketing. David joins Positron Corporation with over 20 years of medical device sales and marketing experience. In addition, he has over ten years of direct management experience in growing revenue and strategic positioning.
David Yeh stated, "Positron is a founder and leader in PET technology and my goal is to revitalize our sales and marketing efforts to position our high resolution, fast imaging and fusion technology bringing Positron's PET to the highest level of performance. Positron continues to develop new technologies to meet the demanding needs of physicians while providing economical and clinical value."
Gary Brooks, Chairman and CEO of Positron, commented, "We are extremely pleased to have an employee of David's quality and qualifications on board. We look forward to his contributions to our Sales and Marketing Organizations." Mr. Brooks added that, "With our recent alliance with Imagin Diagnostic Centres, Inc. of Canada, and our projected push into Asia and Europe, David will be in charge of a dramatically enlarged global task. I believe David will be extremely effective in taking Positron to the next level and help us achieve significant results."
Positron Corporation is primarily engaged in designing, manufacturing, marketing and supporting advanced medical imaging devices utilizing positron emission tomography (PET) technology under the trade name POSICAM(TM) systems. POSICAM(TM) systems incorporate patented and proprietary technology for the diagnosis and treatment of patients in the areas of oncology, cardiology and neurology. POSICAM(TM) systems are in use at leading medical facilities, including the University of Texas - Houston Health Science Center, Hadassah Hebrew University Hospital in Jerusalem, Israel, The Coronary Disease Reversal Center in Buffalo, New York, Emory Crawford Long Hospital Carlyle Fraser Heart Center in Atlanta, and Nishidai Clinic (Diagnostic Imaging Center) in Tokyo. Additional information may be found at http://www.positron.com.
Except for the historical information contained herein, the matters discussed in this news release may contain forward-looking statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are other than statements of historical facts. Certain statements contained herein are forward-looking statements and, accordingly, involve risks and uncertainties which could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. The Company's expectations, beliefs and projections are expressed in good faith and are believed by the Company to have a reasonable basis, including, without limitations, management's examination of historical operating trends, data contained in the Company's records and other data available from third parties, but there can be no assurance that management's expectations, beliefs or projections will result or be achieved or accomplished. In addition to other factors and matters discussed elsewhere herein, the following are important factors that, in the view of the Company, could cause actual results to differ materially from those discussed in the forward-looking statements: the ability of the Company to attain widespread market acceptance of its POSICAM(TM) systems; the ability of the Company to obtain acceptable forms and amounts of financing to fund future operations; demand for the Company's services; and competitive factors. The Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
News 
Market Data 
Discover 
AI
